Skip to main content

Pfizer CRZ 200 (Xalkori 200 mg)

Generic Name: crizotinib

Pill with imprint Pfizer CRZ 200 is Pink & White, Capsule-shape and has been identified as Xalkori 200 mg. It is supplied by Pfizer Inc.

Xalkori is used in the treatment of non-small cell lung cancer; lymphoma and belongs to the drug class multikinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Xalkori 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Pfizer CRZ 200

Xalkori 200 mg Pfizer CRZ 200


Generic Name
Pfizer CRZ 200
200 mg
Pink & White
Prescription only
Drug Class
Multikinase inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Pfizer Inc.
National Drug Code (NDC)
Inactive Ingredients
silicon dioxide, microcrystalline cellulose, calcium phosphate dibasic anhydrous, magnesium stearate, ferric oxide red, titanium dioxide, shellac, propylene glycol, ammonia, potassium hydroxide, ferrosoferric oxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.